Yirsaw Betselot, Gebremeskel Feleke, Gebremichael Gebrekiros, Shitemaw Tewoderos
College of Health Science, Addis Ababa University, Addis Ababa, Ethiopia.
Department of Public Health, Arba Minch University, Arba Minch, Ethiopia.
AIDS Res Ther. 2020 Jun 15;17(1):34. doi: 10.1186/s12981-020-00288-x.
Long acting and permanent contraceptive methods by far are the most effective, very safe and convenient methods than short acting contraceptive methods. But in less developed countries, use of long acting reversible contraceptive or permanent methods (LARCs/PMs) is very low. Therefore the aim of this study was to identify determinants of long acting contraceptive method utilization among HIV positive reproductive age women.
An institutional based case control study was conducted among random sample of 354 HIV positive reproductive age women (total of 97.8% response rate) at Anti-Retroviral Therapy clinics from February 20 to March 20, 2019. Case to control ratio was 1:2. A structured questionnaire and information recorded from ART card review were used to collect the data. Each variable was entered in Bivariate analysis with dependent variables and those variables with P-value of ≤ 0.25 were included in the Multivariate analysis. Significance was determined at the level of P-value < 0.05 with 95% CI of AOR.
A total of 354 (33.3% cases and 66.7% controls) HIV positive reproductive age women were interviewed with response rate of 97.8%. The study revealed being in age group of 39 and above [AOR = 0.17, 95% CI (0.06, 0.48)], being divorced/separated and widowed [AOR = 0.05, 95% CI (0.003, 0.61)], having supportive opinion and strongly supportive opinion regarding family planning service availability in ART clinic [AOR = 5.01, 95% CI (1.79, 14.07)], [AOR = 7.81, 95% CI (2.54, 24.01)] and having no future fertility intention [AOR = 7.03, 95% CI (2.73, 18.06)] were statistically significant determinants for long acting contraceptive method utilization.
Woman in age group of 39 and above, having no future fertility intention and being divorced/separated and widowed was found to be determinants of long acting contraceptive method utilization among HIV positive reproductive age women. In addition our study support the WHO Strategic Considerations for Strengthening the Linkages between Family Planning and HIV/AIDS Policies, Programs, and Services.
长效和永久性避孕方法目前是比短效避孕方法更有效、非常安全且方便的方法。但在欠发达国家,长效可逆避孕法或永久性避孕法(LARCs/PMs)的使用率非常低。因此,本研究的目的是确定HIV阳性育龄妇女长效避孕方法使用的决定因素。
2019年2月20日至3月20日,在抗逆转录病毒治疗诊所对354名HIV阳性育龄妇女的随机样本进行了一项基于机构的病例对照研究(总应答率为97.8%)。病例与对照的比例为1:2。使用结构化问卷和从抗逆转录病毒治疗卡审查中记录的信息来收集数据。每个变量都与因变量进行双变量分析,P值≤0.25的变量纳入多变量分析。显著性以P值<0.05、AOR的95%置信区间来确定。
共采访了354名(33.3%为病例,66.7%为对照)HIV阳性育龄妇女,应答率为97.8%。研究显示,年龄在39岁及以上[AOR = 0.17,95%置信区间(0.06,0.48)]、离婚/分居或丧偶[AOR = 0.05,95%置信区间(0.003,0.61)]、对抗逆转录病毒治疗诊所提供计划生育服务持支持和强烈支持意见[AOR = 5.01,95%置信区间(1.79,14.07)]、[AOR = 7.81,95%置信区间(2.54,24.01)]以及没有未来生育意愿[AOR = 7.03,95%置信区间(2.73,18.06)]是长效避孕方法使用的统计学显著决定因素。
年龄在39岁及以上、没有未来生育意愿以及离婚/分居或丧偶的女性被发现是HIV阳性育龄妇女长效避孕方法使用的决定因素。此外,我们的研究支持世界卫生组织关于加强计划生育与艾滋病毒/艾滋病政策、项目和服务之间联系的战略考虑。